Biomarkers in community acquired pneumonia - What did we learn from the CAPNETZ study?;Biomarker bei ambulant erworbener Pneumonie - Was haben wir aus CAPNETZ gelernt?

Pneumologie

Volumn 65, Issue 2, 2011, Pages 110-113

  Kruger S ^a   Pletz, M W ^b   Rohde, G ^c  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b JENA UNIVERSITY HOSPITAL   (Germany)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENOMEDULLIN; ANTIBIOTIC AGENT; C REACTIVE PROTEIN; PROCALCITONIN;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; DISEASE MARKER; HUMAN; INFLAMMATION; LEUKOCYTE; LONG TERM CARE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS;

ADOLESCENT; ADRENOMEDULLIN; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKERS; BLOOD PRESSURE; C-REACTIVE PROTEIN; CALCITONIN; CARDIOVASCULAR DISEASES; COMMUNITY-ACQUIRED INFECTIONS; COMORBIDITY; ENDOTHELIN-1; FEMALE; GERMANY; HUMANS; INFLAMMATION; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PNEUMONIA; PREDICTIVE VALUE OF TESTS; PROTEIN PRECURSORS; RESPIRATORY RATE; SURVIVAL ANALYSIS; VASOPRESSINS; YOUNG ADULT;

EID: 79651468707     PISSN: 09348387     EISSN: 14388790     Source Type: Journal    
DOI: 10.1055/s-0030-1255935     Document Type: Article

References (13)

1. Krüger S, Ewig S, Papassotiriou J et al, and The CAPNETZ Study group. Inflammatory parameters predict etiologic patterns but do not allow for individual prediction of etiology in patients with CAP - Results from the German competence network CAPNETZ. Respiratory Research 2009 10 65
2. Bauer T T., Ewig S, Marre R, et al, The CAPNETZ study group. CRB-65 predicts death from community-acquired pneumonia. J Intern Med 2006 260 93-101
3. Krüger S, Ewig S, Kunde J, et al, CAPNETZ study group. Pro-vasopressin (copeptin) in patients with community-acquired pneumonia - influence of antibiotic pre-treatment: results from the German competence network CAPNETZ. J Antimicrob Chemother 2009 64 159-162
4. Krüger S, Ewig S, Kunde J, et al, and The CAPNETZ Study group. Assessment of inflammatory markers in patients with community-acquired pneumonia - influence of antimicrobial pre-treatment. Results from the German competence network CAPNETZ. Clin Chim Acta 2010 Aug 7 [Epub ahead of print]
5. Krüger S, Kunde J, Hanschmann A et al. Influence of antibiotic pre-treatment on pro-atrial natriuretic peptide in community-acquired pneumonia. Eur Respir J 2008 32 (Suppl.) 383s
6. Krüger S, Papassotiriou J, Marre R et al. Pro-atrial natriuretic peptide and pro-vasopressin to predict severity and prognosis in community-acquired pneumonia. Results from the German competence network CAPNETZ. Intensive Care Med 2007 33 2069-2078
7. Krüger S, Ewig S, Marre R et al. Procalcitonin predicts patients at low risk of death from community-acquired pneumonia. Eur Resp J 2008 31 349-355
8. Krüger S, Ewig S, Kunde J, et al. and The CAPNETZ Study group. Pro-atrial natriuretic peptide and pro-vasopressin to predict short- and long-term survival in community-acquired pneumonia. Results from the German competence network CAPNETZ. Thorax 2010 65 208-214
9. Krüger S, Ewig S, Giersdorf S, et al. and The CAPNETZ Study group. Cardiovascular and inflammatory biomarkers to predict short- and long-term survival in community-acquired pneumonia. Results from the German competence network CAPNETZ. Am J Respir Crit Care Med 2010; Jul 16 [Epub ahead of print]
10. Burkhardt O, Ewig S, Haagen U et al. A simple procalcitonin-guided strategy results in safe reductions of antibiotic use in patients with symptoms of acute respiratory tract infections in primary care. Eur Respir J 2010; Feb 25 [Epub ahead of print]
11. Christ-Crain M, Jaccard-Stolz D, Bingisser R et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet 2004 363 600-607
12. Christ-Crain M, Stolz D, Bingisser R et al. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: A randomized trial. Am J Respir Crit Care Med 2006 174 84-93
13. Schuetz P, Christ-Crain M, Thomann R et al. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. JAMA 2009 302 1059-1066